Predictors and Outcomes of Intraoperative Hypothermia in Patients Undergoing Knee Arthroplasty
Sponsor
Aga Khan University (Other)
Overall Status
Completed
CT.gov ID
NCT04575246
Collaborator
(none)
286
24
Study Details
Study Description
Brief Summary
The study is designed to retrospectively assess the risk factors associated with intra-operative hypothermia in patients undergoing total knee arthroplasty from January 2016 to December 2017 at Aga Khan University and also understand it's impact on post-operative outcomes.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
286 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Predictors and Outcomes of Intraoperative Hypothermia in Patients Undergoing Total Knee Arthroplasty: A Retrospective Cross-sectional Study From a Developing Country
Actual Study Start Date
:
Jan 1, 2016
Actual Primary Completion Date
:
Dec 31, 2017
Actual Study Completion Date
:
Dec 31, 2017
Outcome Measures
Primary Outcome Measures
- Surgical Site Infection (SSI) [2016-2017]
Post-operative infection caused total knee arthroplasty
- Post-operative hypothermia [Within an hour after surgery]
Body temperature after surgery when patient is in the recovery room.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- All adults greater than 18 years who underwent total knee arthroplasty.
Exclusion Criteria:
- Any patient below 18 years
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Aga Khan University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Anum Sadruddin,
Research Associate,
Aga Khan University
ClinicalTrials.gov Identifier:
NCT04575246
Other Study ID Numbers:
- 2019-1274-3270
First Posted:
Oct 5, 2020
Last Update Posted:
Oct 8, 2020
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: